TlCl injection.
More intense uptake in the lesion compared to the normal side was considered as 'high', the same degree of uptake was considered 'iso', and decreased uptake was 'low'. The retention index (RI) was calculated in 9 patients in the malignant group and in 16 patients in the benign group. Results In malignant tumors, 15 of 19 patients showed high uptake in both the early and delayed phases. One malignant fibrous histiocytoma patient was high only in the delayed phase and 1 liposarcoma patient was high only in the early phase. Two liposarcoma patients showed an iso uptake in both phases. One of these patients was pathologically diagnosed as a myxoid type. In benign lesions, no lipoma showed increased uptake. All neurogenic tumors except for 2 demonstrated high uptake. All 3 ganglions of the lower extremities showed iso uptake. Most inflammatory diseases showed increased uptake. Clinically-considered benign patients consisted of tumorous lesions or inflammatory disease. Only 2 patients were considered 'low', and these were diagnosed as intramuscular hematoma and cyst. RI was variable in both malignant and benign lesions and no statistically significant difference was seen between malignant and benign lesions by ttest (p=0.72). Conclusions A high 201 TlCl uptake lesion is more frequently seen in malignant tumors, but regardless of whether the tumor is benign or malignant, according to the histopathological variety, the other factors such as vascularity, cell densities or tissue viability regardless of whether the tumor is benign or malignant.
We report here the findings of 201 TlCl scintigraphy and consider how to use this technique to evaluate the character of soft tissue lesions.
PATIENTS AND METHODS
We enrolled 91 consecutive patients who were examined for 201 TlCl scintigraphy (45 males and 46 females, age range 8-91-years-old) in this study. Nineteen patients were malignant and 72 were benign. All 19 patients with malignant lesions were pathologically proven ; 46 of 72 patients with benign lesions were pathologically proven, and the other 26 patients were clinically diagnosed as benign with at least 6 months of follow up with physical examinations and magnetic resonance imaging. Patients had 111 MBq of 201 TlCl, and were scanned 15 minutes (early phase) and 3 hours (delayed phase) after the injection. In the early phase, whole body images and a spot scan of the lesion were obtained and a spot scan was performed in the delayed phase. For visual analysis, more intense uptake compared to the normal side was considered as 'high', the same degree (could not be identified as a tumor) of uptake was considered 'iso', and decreased uptake was 'low'. The retention index (RI) was calculated in 9 patients in the malignant group and in 16 patients in the benign group as follows : RI=(DR-ER)/ER! 100 (%). ER (early ratio) is the ratio of lesion count to contralateral soft tissue count in the early phase and DR (delayed ratio) is the ratio of lesion count to contralateral soft tissue count in the delayed phase.
RESULTS
A summary of the patients is shown in Tables 1  and 2 . In malignant tumors, 15 of 19 patients showed high uptake in both the early and delayed phases ( Figure 1 ). One malignant fibrous histiocytoma patient was high only in the delayed phase and 1 liposarcoma patient was high only in the early phase. Two liposarcoma patients showed an iso uptake in both phases. One of these patients was pathologically diagnosed as a myxoid type ( Figure 2 ) ; while the other had fluoro-deoxy-glucose positron emission computed tomography/computed tomography (FDG-PET/CT) for follow up of uterine cervical cancer and was incidentally noticed to have increased nodular uptake in her leg. The tumor showed iso 201 TlCl uptake and was considered benign at the time, but in the follow up period, a malignant component was suspected and it was surgically resected 1.5 years after 201 TlCl scintigraphy, and it was confirmed as liposarcoma pathologically. In benign lesions, no lipoma showed high uptake (Figure 3 ). All neurogenic tumors except for 2 demonstrated high uptake (Figure 4 ). All 3 ganglions of the 201 TlCl injection. More intense uptake in the lesion compared to the normal side was considered as 'high', the same degree of uptake was considered 'iso', and decreased uptake was 'low'. lower extremities showed iso uptake. Most inflammatory diseases showed high uptake. Clinically -considered benign patients (no pathology) consisted of tumorous lesions (mainly lipoma and neurogenic tumor) or inflammatory disease. These tumors are stable or remitted clinically. Only 2 patients were considered 'low', and these were diagnosed as intramuscular hematoma and cyst by MRI and CT, respectively. RI was obtained in only high uptake patients. RI was variable in both malignant and benign lesions and no statistically significant difference was seen between malignant and benign lesions by t-test (p=0.72) ( Figure 5 ). 
DISCUSSION
It is important to evaluate the nature of a lesion and differentiate malignant from benign in the management of patients with soft tissue tumors. Imaging techniques are essential and 201 TlCl scintigraphy has played an important role. FDG-PET is newly developed in tumor imaging but the clinical indication for soft tissue tumor is limited and not so widely used compared with 201 TlCl scintigraphy (5). Thallium is a potassium analogue and accumulates in tumors reflecting many factors. There are some reports that have described the utility of 201 TlCl scintigraphy in the differentiation of malignant from benign lesions based on the degree of 201 TlCl uptake. In dual time scanning (early and delayed phase), the early phase uptake mainly reflects tumor vascularity and the delayed phase uptake substantially reflects tumor viability. In our study, most of the malignant lesions demonstrated high uptake in both the early and delayed phases. Two of the malignant tumors that showed iso uptake were liposarcoma. In these cases, Gadolinium-enhanced MRI was useful to detect illdefined malignant soft tissue components. It is reported that a low 201 TlCl uptake is shown in welldifferentiated or myxoid liposarcoma (6) . One of our patients was incidentally detected by FDG-PET/CT for follow up of uterine cervical cancer, and the lesion showed high FDG uptake. The tumor was resected 1.5 years after 201 TlCl scintigraphy and was proven as liposarcoma. We were unable to determine the existence of a malignant component at the time of 201 TlCl scintigraphy. The RI is reportedly useful for differentiating benign from malignant tumors. In our study, we calculated RI in high uptake patients. The RI was variable in both malignant and benign lesions, and no statistically significant difference was observed. We believe that this is due to histological variability, variable lesion size and normal physiological muscle uptake. We evaluated RI using planar images that demonstrated an overlapped uptake in the lesion and normal muscle. A small lesion is sometimes masked by surrounding tissue and may not show high uptake.
A high 201 TlCl uptake is more frequently seen in malignant tumors, but regardless of whether the tumor is benign or malignant, according to the histopathological variety, the 201 TlCl uptake pattern can not be the only indicator to differentiate malignant from benign tumors. We ultimately need to evaluate the nature of tumors by a combination of several imaging techniques.
